Product Information
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.4123 per EA under NDC 00228315403. Its NADAC has been published 461 times since Nov 28, 2013.
Strength
2; .5 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228315403
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091422On Market Since
3/4/2013
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has been published 461 times since Nov 28, 2013, and over the history we have for it it has declined 88.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4123 per EA |
|---|---|
| All-time high | $3.7455 (Aug 13, 2014) |
| All-time low | $0.3740 (Nov 20, 2024) |
| 52-week high | $0.5463 |
| 52-week low | $0.4123 |
| Median price | $0.7903 |
| Average price | $1.6060 |
| Largest weekly change | -67.5% (Sep 9, 2020) |
| Weeks tracked | 461 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET, manufactured by Actavis Pharma, Inc., is $0.4123 per EA (NDC 00228315403), effective Jun 24, 2026.
How has the price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has declined 88.9%. It has been tracked across 461 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
Since Nov 28, 2013, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has ranged from a low of $0.3740 (Nov 20, 2024) to a high of $3.7455 (Aug 13, 2014), with a median of $0.7903 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET (NDC 00228315403) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification